Toggle Main Menu Toggle Search

Open Access padlockePrints

Pharmacological modulators of tau aggregation and spreading

Lookup NU author(s): Professor Tiago OuteiroORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2020 by the authors. Licensee MDPI, Basel, Switzerland. Tauopathies are neurodegenerative disorders characterized by the deposition of aggregates composed of abnormal tau protein in the brain. Additionally, misfolded forms of tau can propagate from cell to cell and throughout the brain. This process is thought to lead to the templated misfolding of the native forms of tau, and thereby, to the formation of newer toxic aggregates, thereby propagating the disease. Therefore, modulation of the processes that lead to tau aggregation and spreading is of utmost importance in the fight against tauopathies. In recent years, several molecules have been developed for the modulation of tau aggregation and spreading. In this review, we discuss the processes of tau aggregation and spreading and highlight selected chemicals developed for the modulation of these processes, their usefulness, and putative mechanisms of action. Ultimately, a stronger understanding of the molecular mechanisms involved, and the properties of the substances developed to modulate them, will lead to the development of safer and better strategies for the treatment of tauopathies.


Publication metadata

Author(s): Dominguez-Meijide A, Vasili E, Outeiro TF

Publication type: Review

Publication status: Published

Journal: Brain Sciences

Year: 2020

Volume: 10

Issue: 11

Online publication date: 13/11/2020

Acceptance date: 11/11/2020

ISSN (electronic): 2076-3425

Publisher: MDPI AG

URL: https://doi.org/10.3390/brainsci10110858

DOI: 10.3390/brainsci10110858


Share